pharma · Henoch-Schoenlein Purpura Nephritis
Nanjing Children's Hospital
Nanjing Children's Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Henoch-Schoenlein Purpura Nephritis. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Prednisone
Phase 2 · small molecule · Henoch-Schoenlein Purpura Nephritis
Prednisone for Henoch-Schoenlein Purpura Nephritis is a Phase 2 program (small_molecule) at Nanjing Children's Hospital with 1 ClinicalTrials.gov record(s).
Internal code AiZhang
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Nanjing Children's Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Henoch-Schoenlein Purpura Nephritis
- Status
- active
- Trials
- 1